MedPath

Effect of Apo Berymonidin and Latanoprost in optic nerve head perfusio

Phase 2
Conditions
ormal Tension Glaucoma.
Glaucoma
Registration Number
IRCT20120817010617N3
Lead Sponsor
Zahedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients referred to Alzahra Ophthalmology Clinic, who will diagnosed with NTG, based on findings such as: normal ocular pressure, optic, nerve changes, and visual field changes

Exclusion Criteria

patients on treatment
patients with drug allergy
eye surgery
past ophthalmologic diseases history

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Optic nerve head perfusion. Timepoint: one week, one month, three months and six months after initiating drug. Method of measurement: Optical coherence tomography (OCT) imaging test.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath